A United Kingdom supplier, with 4 awarded contracts, most recently 13 months ago.
This contract involves establishing active ingredient-based discount agreements in accordance with § 130a Abs. 8 SGB V for specific pharmaceuticals. The agreements will be in effect for a maximum period of 24 months, starting no earlier than April 1, 2026, and ending uniformly on March 31, 2028. Sup
This procurement process is not subject to public procurement law. It is an Open-House procedure aimed at ensuring transparency and broad information dissemination to interested pharmaceutical companies. This announcement is published in the Supplement to the Official Journal of the European Union.
This contract involves negotiating agreements for the supply of pharmaceuticals and pharmacy-related goods to hospital pharmacies. The plan is to establish one or more contracts for each product. The delivery of the negotiated products will be made to hospital pharmacies for use in accordance with t
This contract involves negotiating agreements for the supply of pharmaceuticals and pharmacy-related goods to hospital pharmacies. The plan is to establish one or more contracts for each product. The delivery of the negotiated products will be made to hospital pharmacies for use in accordance with t
